Cannabis, THC, CBD & Hemp Regulations in Botswana: Complete 2026 Guide
Last updated: September 2026
Botswana maintains a strict prohibition on recreational cannabis while operating a newly established, tightly regulated licensing system for medicinal, scientific, research and industrial cannabis (including low-THC industrial cannabis/hemp). This guide summarises the current legal position as of 2026 under the Cannabis Act 2025 and the Cannabis Regulations 2026, including THC limits, CBD status, penalties and practical advice for residents, investors and travellers.
Legal Status Overview (2026)
- Recreational cannabis: Fully illegal
- Medical / medicinal cannabis: Legal under licence only (medicinal, scientific or research purposes)
- Industrial cannabis (hemp): Legal under licence (≤ 0.7% THC)
- CBD: Not authorised for general consumer sale; restricted to licensed medicinal/industrial channels
- Personal / unlicensed possession: Criminal offence
Recreational cannabis (locally known as matekwane or dagga) remains prohibited under Botswana’s drug laws. In 2025 Parliament passed the Cannabis Act, 2025 (Act No. 20 of 2025). Implementing Cannabis Regulations, 2026 were published in the Extraordinary Gazette of 12 January 2026 (Statutory Instrument No. 3 of 2026). These establish a comprehensive licensing system for cultivation, manufacturing, processing, import, export, transportation, distribution and research, overseen by the National Cannabis Control Authority. The framework is limited to medicinal, scientific, research and industrial purposes and expressly excludes recreational use, personal possession and open consumer sale. Government trials at the National Agricultural Research and Development Institute (NARDI) have been successful, pilot licences have been issued, and commercial production is moving forward as part of economic diversification efforts.
Recreational Cannabis: Complete Prohibition
Possession, use, cultivation, sale and trafficking of cannabis outside the licensed system remain criminal offences. There is no adult-use market, no personal-use exemption and no home-grow allowance for recreational purposes. Travellers have no legal access.
Licensed Medicinal, Scientific and Industrial Framework
The Cannabis Act 2025 and Regulations 2026 create a tightly controlled commercial pathway. Key features include:
- Licences required for cultivation, seed production, nurseries, manufacturing/processing (industrial and medicinal), transport, research, import and export.
- Oversight by the National Cannabis Control Authority, with extensive requirements covering security, business plans, site information, crop management, financial capacity and ongoing compliance/inspections.
- Industrial cannabis (what most jurisdictions call industrial hemp) is defined with a maximum THC concentration of 0.7%. It is intended for fibre, seed, oil extraction, industrial processing, textiles, construction materials (e.g., hempcrete), food products and other value-added uses — not for intoxication or commercial flower sales.
- Medicinal cannabis activities are permitted under dedicated licences for pharmaceutical/medical purposes.
- Pilot cultivation licences have already been granted; a public farm at Dibete has been selected for early-phase activity. Collaboration with NARDI for research and skills transfer is required in authorised projects.
- The framework is designed to comply with international narcotics conventions while enabling economic diversification away from diamond dependence.
CBD and other cannabinoids are not authorised for open consumer retail under the regulations. Commercial production or sale of flowers for non-medicinal purposes is not permitted.
THC, CBD and Hemp Status
- Industrial cannabis / hemp: ≤ 0.7% THC under the licensed framework. Cultivation, processing and related activities require a licence from the National Cannabis Control Authority. Unlicensed activity remains illegal.
- Medicinal cannabis: Permitted only under specific medicinal/scientific licences. Products are intended for regulated medicinal or research use, not general consumer sale.
- CBD: Not registered by the Botswana Medicines Regulatory Authority (BoMRA) for general consumer or over-the-counter sale. Imports of CBD products risk seizure by customs (BURS). CBD falls within the controlled licensing system; unlicensed possession or retail is not permitted.
Products that are legal in neighbouring countries (including limited CBD products from South Africa) should not be assumed lawful in Botswana.
Penalties for Violations
Unauthorised cannabis activity remains subject to Botswana’s drug laws. UK FCDO travel advice warns that a drug conviction can attract a fine of up to 500,000 pula or imprisonment for up to 25 years. Secondary reporting has cited tiered figures for possession (lower penalties for smaller quantities, higher for larger amounts), but the overall risk is severe. Licensed operators who breach licence conditions face regulatory sanctions, licence revocation and potential criminal liability.
Practical Reality for Travellers, Residents and Investors
There is no legal route for a traveller or ordinary resident to buy, possess or use recreational cannabis or unlicensed CBD products. Informal availability does not equal legality. Foreign medical prescriptions have no general recognition outside the licensed Botswana system.
Commercial operators and investors must obtain the appropriate licences under the Cannabis Act 2025 and Regulations 2026, meet strict security, financial and operational requirements, and comply with National Cannabis Control Authority oversight. Domestic consumer sales of cannabis or CBD products remain closed outside authorised medicinal channels.
Comparison with Neighbouring / Regional Countries (2026 Snapshot)
| Country | Recreational | Medical / Industrial | CBD / Hemp Notes |
|---|---|---|---|
| Botswana | Illegal | Licensed (Cannabis Act 2025; industrial ≤ 0.7% THC) | Tightly regulated; no open CBD retail |
| South Africa | Private adult use limited | Limited framework | CBD under dosage rules |
| Zimbabwe | Illegal | Licensed medical/industrial | Export-oriented licensing |
| Zambia | Illegal | Licensed (industrial hemp ≤ 0.3% THC) | Export-oriented; no domestic retail |
| Malawi | Illegal | Licensed (CRA; industrial ≤ 1% THC) | Licensed medical & industrial pathway |
| Namibia | Illegal | Illegal / limited | Mostly prohibitionist |
Frequently Asked Questions
Is weed legal in Botswana in 2026?
Recreational cannabis is illegal. Licensed medicinal, scientific, research and industrial cannabis activities are permitted under the Cannabis Act 2025 and Regulations 2026, but there is no personal or recreational market.
Is CBD legal in Botswana?
CBD is not authorised for general consumer sale. BoMRA has not registered consumer CBD products. CBD falls under the licensed medicinal/industrial framework; unlicensed possession or importation carries legal risk.
Can I grow industrial hemp in Botswana?
Yes, but only with a licence under the Cannabis Act 2025 / Regulations 2026. Industrial cannabis is capped at 0.7% THC. Unlicensed cultivation remains illegal. Government trials have succeeded and commercial licensing has begun.
What are the penalties for possession?
Unauthorised possession is a criminal offence. A drug conviction can attract a fine of up to 500,000 pula or imprisonment for up to 25 years. Exact outcomes depend on quantity and circumstances.
Do foreign medical prescriptions work?
No general recognition exists for foreign prescriptions outside the licensed Botswana system. Travellers should not bring cannabis or CBD products into the country.
Conclusion and Outlook for 2026–2027
As of September 2026 Botswana operates a dual regime: recreational cannabis remains fully prohibited, while a comprehensive licensing system for medicinal, scientific, research and industrial cannabis (including industrial cannabis at ≤ 0.7% THC) is in force under the Cannabis Act 2025 and the Cannabis Regulations 2026. The National Cannabis Control Authority oversees the sector. Government trials have been successful, pilot licences have been issued, and commercial production is advancing as part of economic diversification. CBD and other cannabinoids are not available for open consumer sale. Unlicensed activity continues to carry severe penalties.
Anyone considering travel, personal use, research or investment must treat unlicensed activity as high-risk and obtain current advice from a qualified Botswana lawyer or the National Cannabis Control Authority. Always verify the latest licence requirements, fee schedules and enforcement practice with official sources.
This article is for informational purposes only and does not constitute legal advice. Always consult official sources (National Cannabis Control Authority, Botswana Medicines Regulatory Authority, and qualified local counsel) before taking any action related to controlled substances in Botswana.